Michael Wang

16PUBLICATIONS
44CO-AUTHORS
Cardiology (incl. cardiovascular diseases)HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiovascular medicine and haematology not elsewhere classifiedRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 16, 2022
The Hemophilia Gene Therapy Patient Journey: Questions and Answers for Shared Decision-Making.

Michael Wang, Claude Negrier, Frank Driessler

|Apr 27, 2022
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors.

Steven W Pipe, Cédric Hermans, Meera Chitlur

|Oct 12, 2021
The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors.

Miguel Escobar, Giancarlo Castaman, Santiago Bonanad Boix

|Oct 06, 2021
PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors.

Miguel Escobar, James Luck, Yevhenii Averianov

|Feb 01, 2021
Impact of haemophilia on patients with mild-to-moderate disease: Results from the P-FiQ and B-HERO-S studies.

Michelle Witkop, Michael Wang, Grace Hernandez

Pageof 3